As a result, RSK inhibition not only attenuated pS473-TRIM28 but also abolished E2F1-driven CRPC cell proliferation in vitro and Rb-deficient xenograft tumor growth in vivo. The gene discussed is RPS6KA1; the disease is neoplasm.